188 related articles for article (PubMed ID: 22170412)
1. Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam.
Maehata Y; Esaki M; Morishita T; Kochi S; Endo S; Shikata K; Kobayashi H; Matsumoto T
J Gastroenterol; 2012 Apr; 47(4):387-93. PubMed ID: 22170412
[TBL] [Abstract][Full Text] [Related]
2. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo.
Goldstein JL; Eisen GM; Lewis B; Gralnek IM; Zlotnick S; Fort JG;
Clin Gastroenterol Hepatol; 2005 Feb; 3(2):133-41. PubMed ID: 15704047
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-Inflammatory Drug-Induced Small Bowel Injury: A Randomized, Placebo-Controlled Trial.
Washio E; Esaki M; Maehata Y; Miyazaki M; Kobayashi H; Ishikawa H; Kitazono T; Matsumoto T
Clin Gastroenterol Hepatol; 2016 Jun; 14(6):809-815.e1. PubMed ID: 26538205
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study.
Huang WF; Hsiao FY; Tsai YW; Wen YW; Shih YT
Drug Saf; 2006; 29(3):261-72. PubMed ID: 16524325
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of selective cyclooxygenase-2 inhibitor-induced small bowel injury: randomized cross-over study compared with loxoprofen in healthy subjects.
Mizukami K; Murakami K; Yamauchi M; Matsunari O; Ogawa R; Nakagawa Y; Okimoto T; Kodama M; Fujioka T
Dig Endosc; 2013 May; 25(3):288-94. PubMed ID: 23369024
[TBL] [Abstract][Full Text] [Related]
6. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
[TBL] [Abstract][Full Text] [Related]
7. Safe administration of celecoxib to a patient with repeated episodes of nephrotic syndrome induced by NSAIDs.
Mihovilovic K; Ljubanovic D; Knotek M
Clin Drug Investig; 2011; 31(5):351-5. PubMed ID: 21271751
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of small bowel injury by switching from nonselective nonsteroidal anti-inflammatory drugs to celecoxib in rheumatoid arthritis patients: a pilot study.
Inoue T; Iijima H; Arimitsu J; Hagihara K; Kawai S; Shiraishi E; Hiyama S; Mukai A; Shinzaki S; Nishida T; Ogata A; Tsujii M; Takehara T
Digestion; 2014; 89(2):124-32. PubMed ID: 24526219
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
Layton D; Hughes K; Harris S; Shakir SA
Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.
Layton D; Hughes K; Harris S; Shakir SA
Rheumatology (Oxford); 2003 Nov; 42(11):1354-64. PubMed ID: 12867585
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Simon LS; Weaver AL; Graham DY; Kivitz AJ; Lipsky PE; Hubbard RC; Isakson PC; Verburg KM; Yu SS; Zhao WW; Geis GS
JAMA; 1999 Nov; 282(20):1921-8. PubMed ID: 10580457
[TBL] [Abstract][Full Text] [Related]
12. [Tolerance to celecoxib and meloxicam in patients with intolerance to nonsteroidal anti-inflammatory drugs].
Vázquez-Cortés S; Vázquez-Fuertes L; Rodríguez-Alvarez M; Reig Rincón de Arellano I; Martínez-Cócera C
An Med Interna; 2008 Apr; 25(4):163-7. PubMed ID: 18604331
[TBL] [Abstract][Full Text] [Related]
13. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury.
Scheiman JM; Cryer B; Kimmey MB; Rothstein RI; Riff DS; Wolfe MM
Clin Gastroenterol Hepatol; 2004 Apr; 2(4):290-5. PubMed ID: 15067622
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib Monotherapy Maintained Small Intestinal Mucosa Better Compared With Loxoprofen Plus Lansoprazole Treatment: A Double-blind, Randomized, Controlled Trial.
Fujimori S; Hanada R; Hayashida M; Sakurai T; Ikushima I; Sakamoto C
J Clin Gastroenterol; 2016 Mar; 50(3):218-26. PubMed ID: 26166140
[TBL] [Abstract][Full Text] [Related]
16. New cyclooxygenase-2 inhibitors for treatment of experimental autoimmune neuritis.
Miyamoto K; Oka N; Kawasaki T; Miyake S; Yamamura T; Akiguchi I
Muscle Nerve; 2002 Feb; 25(2):280-2. PubMed ID: 11870698
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
Lipscomb GR; Wallis N; Armstrong G; Rees WD
Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa.
Moberly JB; Harris SI; Riff DS; Dale JC; Breese T; McLaughlin P; Lawson J; Wan Y; Xu J; Truitt KE
Dig Dis Sci; 2007 Feb; 52(2):442-50. PubMed ID: 17216336
[TBL] [Abstract][Full Text] [Related]
19. Meloxicam-induced enteropathy of the small bowel.
Are C; Turagam M; Aucar JA; Greenberg E
CMAJ; 2011 Mar; 183(5):577-80. PubMed ID: 20974723
[No Abstract] [Full Text] [Related]
20. Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent.
Harirforoosh S; Aghazadeh-Habashi A; Jamali F
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):917-24. PubMed ID: 17002668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
